Makiko Yasuda

2.9k total citations · 1 hit paper
42 papers, 2.1k citations indexed

About

Makiko Yasuda is a scholar working on Molecular Biology, Physiology and Rheumatology. According to data from OpenAlex, Makiko Yasuda has authored 42 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 14 papers in Physiology and 13 papers in Rheumatology. Recurrent topics in Makiko Yasuda's work include Porphyrin Metabolism and Disorders (25 papers), Heme Oxygenase-1 and Carbon Monoxide (21 papers) and Lysosomal Storage Disorders Research (13 papers). Makiko Yasuda is often cited by papers focused on Porphyrin Metabolism and Disorders (25 papers), Heme Oxygenase-1 and Carbon Monoxide (21 papers) and Lysosomal Storage Disorders Research (13 papers). Makiko Yasuda collaborates with scholars based in United States, Japan and France. Makiko Yasuda's co-authors include Robert J. Desnick, Geetha Thiagarajan, Hitoshi Sakuraba, Severo Pagliardini, Turgut Tükel, Marco Spada, Alberto Ponzone, Junaid Shabbeer, Brenden Chen and Stacy D. Benson and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Makiko Yasuda

42 papers receiving 2.0k citations

Hit Papers

High Incidence of Later-O... 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Makiko Yasuda United States 19 1.2k 956 565 504 378 42 2.1k
Kenneth H. Astrin United States 24 561 0.5× 1.1k 1.1× 318 0.6× 391 0.8× 171 0.5× 45 1.7k
Kazuko Sukegawa Japan 30 1.8k 1.6× 627 0.7× 934 1.7× 486 1.0× 618 1.6× 100 2.3k
Vũ Chí Dũng Vietnam 18 729 0.6× 298 0.3× 319 0.6× 222 0.4× 236 0.6× 38 1.1k
R J Desnick United States 12 778 0.7× 245 0.3× 309 0.5× 212 0.4× 198 0.5× 20 941
Hagit Baris Israel 17 327 0.3× 385 0.4× 156 0.3× 69 0.1× 106 0.3× 49 965
Motomichi Kosuga Japan 19 500 0.4× 239 0.3× 223 0.4× 179 0.4× 88 0.2× 54 839
Rosanna Gatti Italy 17 422 0.4× 298 0.3× 141 0.2× 195 0.4× 151 0.4× 35 808
Alison McVie‐Wylie United States 14 742 0.6× 575 0.6× 238 0.4× 394 0.8× 178 0.5× 20 1.2k
Esmée Oussoren Netherlands 15 383 0.3× 245 0.3× 169 0.3× 166 0.3× 67 0.2× 32 768
P Guibaud France 19 349 0.3× 548 0.6× 122 0.2× 146 0.3× 39 0.1× 60 1.1k

Countries citing papers authored by Makiko Yasuda

Since Specialization
Citations

This map shows the geographic impact of Makiko Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makiko Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makiko Yasuda more than expected).

Fields of papers citing papers by Makiko Yasuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makiko Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makiko Yasuda. The network helps show where Makiko Yasuda may publish in the future.

Co-authorship network of co-authors of Makiko Yasuda

This figure shows the co-authorship network connecting the top 25 collaborators of Makiko Yasuda. A scholar is included among the top collaborators of Makiko Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makiko Yasuda. Makiko Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simonaro, Calogera M., Makiko Yasuda, & Edward H. Schuchman. (2024). Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders. Journal of Inherited Metabolic Disease. 48(1). e12813–e12813. 1 indexed citations
2.
Balwani, Manisha, Sioḃán Keel, Peter N. Meissner, et al.. (2024). Case‐based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management. Liver International. 45(3). e15924–e15924. 1 indexed citations
3.
Chen, Yen‐Hsi, Weihua Tian, Makiko Yasuda, et al.. (2023). A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution. Frontiers in Bioengineering and Biotechnology. 11. 1128371–1128371. 4 indexed citations
5.
Yasuda, Makiko, Sioḃán Keel, & Manisha Balwani. (2023). RNA interference therapy in acute hepatic porphyrias. Blood. 142(19). 1589–1599. 10 indexed citations
6.
Yasuda, Makiko & Robert J. Desnick. (2019). Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies. Molecular Genetics and Metabolism. 128(3). 332–341. 13 indexed citations
7.
Chen, Brenden, Angelika Erwin, Manisha Balwani, et al.. (2019). Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria. Journal of Inherited Metabolic Disease. 42(1). 186–194. 16 indexed citations
8.
Pulgar, Víctor M., Makiko Yasuda, Lin Gan, Robert J. Desnick, & Herbert L. Bonkovsky. (2019). Sex differences in vascular reactivity in mesenteric arteries from a mouse model of acute intermittent porphyria. Molecular Genetics and Metabolism. 128(3). 376–381. 10 indexed citations
9.
Yasuda, Makiko, et al.. (2018). Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations. Molecular Genetics and Metabolism. 128(3). 352–357. 2 indexed citations
10.
Yasuda, Makiko, Brenden Chen, & Robert J. Desnick. (2018). Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes. Molecular Genetics and Metabolism. 128(3). 320–331. 49 indexed citations
11.
Wakabayashi, Aoi, Jacob C. Ulirsch, Leif S. Ludwig, et al.. (2016). Insight into GATA1 transcriptional activity through interrogation ofciselements disrupted in human erythroid disorders. Proceedings of the National Academy of Sciences. 113(16). 4434–4439. 38 indexed citations
12.
Chen, Brenden, Jörg Hakenberg, Wanqiong Qiao, et al.. (2016). Acute Intermittent Porphyria: Predicted Pathogenicity ofHMBSVariants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease. Human Mutation. 37(11). 1215–1222. 126 indexed citations
13.
Chan, Amy, Abigail Liebow, Makiko Yasuda, et al.. (2015). Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification. Molecular Therapy — Nucleic Acids. 4. e263–e263. 108 indexed citations
14.
Yasuda, Makiko, Angelika Erwin, Lawrence U. Liu, et al.. (2015). Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver. Molecular Medicine. 21(1). 487–495. 44 indexed citations
16.
Zhang, Jinglan, Makiko Yasuda, Robert J. Desnick, et al.. (2011). A LC–MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen. Journal of Chromatography B. 879(24). 2389–2396. 39 indexed citations
17.
Yasuda, Makiko, David F. Bishop, Mary Fowkes, et al.. (2009). AAV8-mediated Gene Therapy Prevents Induced Biochemical Attacks of Acute Intermittent Porphyria and Improves Neuromotor Function. Molecular Therapy. 18(1). 17–22. 41 indexed citations
18.
Yasuda, Makiko, et al.. (2007). Acute intermittent porphyria: vector optimization for gene therapy. The Journal of Gene Medicine. 9(9). 806–811. 6 indexed citations
19.
Bishop, David F., Annika Johansson, Robert Phelps, et al.. (2006). Uroporphyrinogen III Synthase Knock-In Mice Have the Human Congenital Erythropoietic Porphyria Phenotype, Including the Characteristic Light-Induced Cutaneous Lesions. The American Journal of Human Genetics. 78(4). 645–658. 17 indexed citations
20.
Ashley, Grace A., Junaid Shabbeer, Makiko Yasuda, Christine M. Eng, & Robert J. Desnick. (2001). Fabry disease: twenty novel α-galactosidase A mutations causing the classical phenotype. Journal of Human Genetics. 46(4). 192–196. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026